COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, cardiovascular orthopedic and wound care areas, announced today that C. Randal Mills, Ph.D., President and Chief Executive Officer, is scheduled to present at the 10th Annual JMP Securities Research Conference on Tuesday, May 10, 2011 at 12:00 p.m. PT.
